Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

teva b.v. - azathioprine natrium samenstelling overeenkomend met; azathioprine; - poeder voor oplossing voor injectie - azathioprine

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

mylan b.v. dieselweg 25 3752 lb bunschoten - azathioprine 25 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460(i)) ; croscarmellose natrium (e 468) ; hypromellose (e 464) ; mannitol (d-) (e 421) ; maÏszetmeel ; natriumstearylfumaraat ; povidon k 25 (e 1201) ; propyleenglycol (e 1520), cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; hypromellose (e 464) ; mannitol (d-) (e 421) ; maÏszetmeel ; natriumstearylfumaraat ; povidon k 25 (e 1201) ; propyleenglycol (e 1520), - azathioprine

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

mylan b.v. dieselweg 25 3752 lb bunschoten - azathioprine 50 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460(i)) ; croscarmellose natrium (e 468) ; hypromellose (e 464) ; mannitol (d-) (e 421) ; maÏszetmeel ; natriumstearylfumaraat ; povidon k 25 (e 1201) ; propyleenglycol (e 1520), cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; hypromellose (e 464) ; mannitol (d-) (e 421) ; maÏszetmeel ; natriumstearylfumaraat ; povidon k 25 (e 1201) ; propyleenglycol (e 1520), - azathioprine

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - azathioprine 100 mg - filmomhulde tablet - 100 mg - azathioprine 100 mg - azathioprine

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

teva nederland b.v. - azathioprine - filmomhulde tablet - cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; lactose 1-water ; macrogolstearaat, type i ; magnesiumstearaat (e 470b) ; maÏszetmeel ; povidon (e 1201) ; silica, hydrate form unknown (e 551) ; talk (e 553 b) ; titaandioxide (e 171), - azathioprine

Europese Unie - Nederlands - EMA (European Medicines Agency)

nova laboratories ireland limited - azathioprine - graft rejection - immunosuppressiva - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aspen pharma trading ltd. - azathioprine 50 mg - filmomhulde tablet - 50 mg - azathioprine 50 mg - azathioprine

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aspen pharma trading ltd. - azathioprine 25 mg - filmomhulde tablet - 25 mg - azathioprine 25 mg - azathioprine

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

euro registratie collectief b.v. - mercaptopurine 1-water samenstelling overeenkomend met; mercaptopurine 0-water; - tablet - mercaptopurine

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

euro registratie collectief b.v. van der giessenweg 5 2921 lp krimpen a/d ijssel - mercaptopurine 1-water samenstelling overeenkomend met ; mercaptopurine 0-water - tablet - lactose 1-water ; magnesiumstearaat (e 470b) ; maÏszetmeel ; maÏszetmeel, gemodificeerd (modificatie onbekend, (e 1450) ; stearinezuur (e 570), lactose 1-water ; magnesiumstearaat (e 470b) ; maÏszetmeel ; maÏszetmeel, gehydrolyseerd ; stearinezuur (e 570), - mercaptopurine